New therapies shaping the future of amyloidosis
New therapeutic targets in CLL: ROR1
What is the focus of lymphoma research in 2017?
Novel venetoclax combination therapy advancing the field of CLL
Major breakthroughs in AL amyloidosis treatment from ASH 2017